NCT06412029
Understanding and Enhancing Health-Related Social Needs (HRSN) Screening Among Community Oncology Practices
Enrolling by Invitation
Not specifiedAges 18+ObservationalWake Forest University Health SciencesInvestigator-initiated
~144 participants
Updated 2026-07-24 on ClinicalTrials.gov
What's tested:Non-Interventional
At a glance
Recruiting sites
0 of 37 listed sites are recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
HRSN screening reach (Part 1)
Measured over From study enrollment to approximately 4 and 16 weeks post initial study training
+2 more outcomes measured
Conditions
Where it's being run
37 sites across 17 statesIllinois6
Wisconsin4
Iowa3
Michigan3
Minnesota3
Puerto Rico3
Maine2
Missouri2
Study leadership
- Kathryn Weaver, PhD · STUDY_CHAIR · Wake Forest University Health Sciences
Who to contact
This trial hasn't published a contact. View it on ClinicalTrials.gov
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Eligibility criteria
Inclusion
Must be an affiliate or sub-affiliate of an NCORP Community or Minority Underserved Community site
Must provide outpatient oncology care
Must be a NCORP practice (defined as one or more NCORP affiliates/sub-affiliates, that have a common administrative structure and share providers and/or patients)
Must have identified two or more Practice Staff that are available and willing to participate on the Practice Interest Form
Must have identified at least 1-3 outpatient oncology clinics willing to participate on the Practice Interest Form
1-3 clinics within the practice should be selected
Clinics may or may not be located in different physical locations
The investigators will encourage NCORP practices to select clinics within a practice that differ in current or potential implementation of health related social needs (HRSN) screening (e.g., different clinic workflow or staff, different screening triggers, different tools), so that heterogeneity within NCORP practices can be captured
Clinics must be willing to allow Practice Staff participants to observe the clinical operations in-person
Must be willing and able to take time to observe in person and document 1-3 selected clinics within the practice (approximately 2-3 hours per clinic)
Must be staff at the selected and enrolled practice. Suggestions of appropriate staff are cancer care delivery research (CCDR) Lead, research nurse, clinical research coordinator or NCORP Administrators. Staff members with primary clinical roles may also be appropriate, if available
Must be willing and able to participate in two 1.5 hour virtual training sessions
Must be willing to interview Clinic Key Informants (approximately 30 minutes per interview; in-person or remotely over the internet or by phone)
If the clinic is chosen for Part 2, must be willing to schedule an interview between Clinic Key Informant and Wake Forest health HRSN Study Team or designee
If the clinic is chosen for Part 3, must be willing to participate in a three hour or two 1.5 hour in-person (if possible) workshop(s). If the clinic schedules an in-person workshop, there will be no hybrid or separate virtual option for those that cannot attend
Must be willing to be recorded when participating in interviews and the workshop.
Must be willing to participate in Part 1 Operational Assessment, which involves a semi-structured interview (approximately 30 minutes; in-person or remotely over the internet or by phone) and a brief Non-patient Demographics Survey (approximately 5 minutes)
If the clinic is chosen for Part 2, must be willing to participate in an additional 45 minute interview (remotely over the internet or by phone)
If the clinic is chosen for Part 3, must be willing to participate in a three hour or two 1.5 hour in-person (if possible) workshop(s). If the clinic schedules an in-person workshop, there will be no hybrid or separate virtual option for those that cannot attend
Must be a clinic stakeholder (e.g., providers, practice managers, etc.) of the selected clinic
Must be willing and able to participate in a three hour or two 1.5 hour in-person (if possible) recorded workshop. If the clinic schedules an in-person workshop, there will be no hybrid or separate virtual option for those that cannot attend
Must be willing to be recorded when participating in interviews and the workshop.
Must be a prospective clinic stakeholder (e.g., patient representative) of the selected clinic
Must be willing and able to participate in a three hour or two 1.5 hour in-person (if possible) recorded workshop. If the clinic schedules an in-person workshop, there will be no hybrid or separate virtual option for those that cannot attend
Must have received cancer treatment at the selected clinic within the last five years
Must be willing to be recorded when participating in the workshop.
What this trial measures
- HRSN screening reach (Part 1)From study enrollment to approximately 4 and 16 weeks post initial study training
Determining the perception of the proportion of patients at clinics who are screened for health related social needs (HRSN).
- Barriers and facilitators influencing HRSN screening implementationFrom study enrollment to time completion of key informant interviews, approximately within 6 months
Synthesize themes to create a list of barriers and facilitators influencing HRSN screening implementation within high-implementation clinics, moderate-implementation clinics, and low-implementation clinics.
- Generation of a tailored implementation plan for each participating clinicBetween time of clinic selection and co-design workshop completion, to be no more than 6 months
Generation (defined for each clinic as completed or not completed) of a tailored implementation plan for each participating clinic in Part 3 that includes (1) adaptations to current HRSN screening and follow-up processes, and (2) potential implementation strategies to enhance HRSN screening implementation.